CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19
CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminitic drug Niclosamide for treatment of Covid-19. The trial is a multi-centric, phase-II, randomized, open label clinical study to evaluate...